SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-207568
Filing Date
2021-07-02
Accepted
2021-07-02 16:01:39
Documents
10
Effectiveness Date
2021-07-02

Document Format Files

Seq Description Document Type Size
1 S-3ASR d192751ds3asr.htm S-3ASR 407381
2 EX-1.2 d192751dex12.htm EX-1.2 206109
3 EX-4.2 d192751dex42.htm EX-4.2 124293
4 EX-4.3 d192751dex43.htm EX-4.3 120604
5 EX-4.6 d192751dex46.htm EX-4.6 84368
6 EX-4.7 d192751dex47.htm EX-4.7 298927
7 EX-5.1 d192751dex51.htm EX-5.1 30367
8 EX-23.1 d192751dex231.htm EX-23.1 1814
9 GRAPHIC g192751g0702083415224.jpg GRAPHIC 2403
10 GRAPHIC g192751g33e42.jpg GRAPHIC 45835
  Complete submission text file 0001193125-21-207568.txt   1341588
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-257636 | Film No.: 211069829
SIC: 2834 Pharmaceutical Preparations